The evolving landscape of the economics of HIV treatment and prevention.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 22347816.
- Also identified by DOI 10.1371/journal.pmed.1001174 and PMC identifier 3279512.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Bohdan Nosyk and Julio Montaner argue that the cost-effectiveness of HAART roll out has been significantly underestimated because economic analyses haven't yet taken into account the beneficial impact of HAART on HIV transmission.
Medical subject headings
- Antiretroviral Therapy, Highly Active
- HIV Infections